Intra-operative preparation of autologous bone marrow-derived CD34-enriched cellular products for cardiac therapy

Cytotherapy

Volumn 13, Issue 4, 2011, Pages 441-448

  Donnenberg, Albert D ^a,b   Donnenberg, Vera S ^a,b   Griffin, Deborah L ^b   Moore, Linda R ^b   Tekinturhan, Ferda ^c   Kormos, Robert L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Baxter Isolex; bone marrow; CD34 selection; fl ow cytometry; Hetastarch

Indexed keywords

CD45 ANTIGEN; HETASTARCH;

ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW BIOPSY; BONE MARROW CELL; CD34 SELECTION; CELL HETEROGENEITY; CELL VIABILITY; CORONARY ARTERY BYPASS GRAFT; ERYTHROCYTE; FLOW CYTOMETRY; HEART ASSIST DEVICE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; INTRAOPERATIVE PERIOD; PRIORITY JOURNAL; TISSUE REGENERATION; TREATMENT OUTCOME;

EID: 79952640204     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2010.529888     Document Type: Article

References (15)

1. + cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213-26.
2. Donnenberg AD, Koch EK, Griffin DL, Stanczak HM, Kiss JE, Carlos TM, et al. Viability of cryopreserved BM progenitor cells stored for more than a decade. Cytotherapy. 2002;4:157-63. (Pubitemid 34537335)
3. + marrow cells in patients with breast cancer or neuroblastoma. Blood. 1991;77:1717-22.
4. Shpall E, Jones R, Bearman S, Franklin W, Archer P, Curiel T, et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: infl uence of CD34-positive peripheralblood progenitors and growth factors on engraftment. J Clin Oncol. 1994;12:28-36.
5. + bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood. 1995;85:1647-54.
6. McKenna DH, Adams S, Sumstad D, Sumstad T, Kadidlo D, Gee AP, et al. CD34 cell selection using small-volume marrow aspirates: a platform for novel cell therapies and regenerative medicine. Cytotherapy. 2010;12:170-7.
7. Wagner JE, Santos GW, Noga SJ, Rowley SD, Davis J, Vogelsang GB, et al. Bone marrow graft engineering by coun-terflow centrifugal elutriation: results of a phase I-II clinical trial. Blood. 1990;75:1370-7. (Pubitemid 20107307)
8. Spitzer TR, Davis JM. Buffy coat preparation using the haemonetics model 30. In: Areman EM, Deeg HJ, Sacher RA. Bone Marrow and Stem Cell Processing: A Manualof Current Techniques. Philadelphia: FA Davis; 1992. p. 113-7.
9. Spitzer TR, Donnelly SF Red blood cell sedimentation. In: Areman EM, Deeg HJ, Sacher RA. Bone Marrow and Stem Cell Processing: A Manualof Current Techniques. Philadelphia: FA Davis; 1992. p. 126-9.
10. Warkentin PI, Hilden JM, Kersey JH, Ramsay NK, McCullough J. Transplantation of major ABO-incompatible bone marrow depleted of red cells by hydroxyethyl starch. Vox Sang. 1985;48:89-104. (Pubitemid 15196058)
11. Donnenberg AD. T-cell depletion and allograft engineering. In: Ball ED, Lister J, Law P. Hematopoietic Stem Cell Therapy. Philadelphia: Churchill Livingstone; 2000. p. 335-44.
12. Donnenberg VS, Donnenberg AD, Zimmerlin L, Landreneau RJ, Bhargava R, Wetzel RA, et al. Localization of CD44 and CD90 positive cells to the invasive front of breast tumors. Clin Cytom. 2010;78B(5)287-301.
13. Pierelli L, Bonanno G, Rutella S, Marone M, Scambia G, Leone G. CD105 (Endoglin) expression on hematopoietic stem/progenitor cells. Leuk Lymph. 2001;42:1195-206. (Pubitemid 34082907)
14. + stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation. 2007; 115:3165-72. (Pubitemid 47018140)
15. Kawamoto A, Iwasaki H, Kusano K, Murayama T, Oyamada A, Silver M, et al. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation. 2006;114:2163-9. (Pubitemid 44747897)